CTGF mediates TGF-β-induced fibronectin matrix deposition by upregulating active α5β1 integrin in human mesangial cells

Journal of the American Society of Nephrology

Volumn 14, Issue 3, 2003, Pages 601-610

  Weston, Benjamin S ^a   Wahab, Nadia Abdel ^a   Mason, Roger M ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CONNECTIVE TISSUE GROWTH FACTOR; FIBRONECTIN; INTEGRIN; MONOCLONAL ANTIBODY; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 5;

ARTICLE; CELL ADHESION; CELL CULTURE; CELL SURFACE; CONTROLLED STUDY; DIABETIC RETINOPATHY; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; GENE INDUCTION; GENETIC TRANSCRIPTION; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; IN VITRO STUDY; LIGAND BINDING; MESANGIUM; MESANGIUM CELL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; UPREGULATION;

EID: 0037373094     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000051600.53134.B9     Document Type: Article

References (43)

1. nd edition, edited by Pickup J, Williams G, London, Blackwell Scientific Publ, 1997, pp 52.1-52.21
2. Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New Engl J Med 329: 977-986, 1993
3. Chen S, Hong SW, Iglesias-de la Cruz MC, Isono M, Casaretto A, Ziyadeh FN: The key role of the transforming growth factor-beta system in the pathogenesis of diabetic nephropathy. Ren Fail 23: 471-481, 2001
4. Gupta S, Clarkson MR, Duggan J, Brady HR: Connective tissue growth factor: Potential role in glomerulosclerosis and tubulointerstitial fibrosis. Kidney Int 58: 1389-1399, 2000
5. Murphy M, Godson C, Cannon S, Kato S, Mackenzie HS, Martin F, Brady HR: Suppression subtractive hybridisation identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells. J Biol Chem 274: 5830-5834, 1999
6. Abdel-Wahab N, Yevdokimova N, Weston BS, Roberts T, Jun Li X, Brinkman H, Mason RM: Role of connective tissue growth factor in the pathogenesis of diabetic nephropathy. Biochem J 359: 77-87, 2001
7. Bradham DM, Igarashi A, Potter RL, Grotendorst GR: Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J Cell Biol 114: 1285-1294, 1991
8. Bork P: The modular architecture of a new family of growth regulators related to connective tissue growth factor. FEBS Lett 327: 125-130, 1993
9. Grotendorst GR, Okochi H, Hayashi N: A novel transforming growth factor beta response element controls the expression of the connective tissue growth factor gene. Cell Growth Differ 7: 469-480, 1996
10. Grotendorst GR: Connective tissue growth factor: a mediator of TGF-β action on fibroblasts. Cytokine Growth Factor Rev 8: 171-179, 1997
11. Riser BL, Cortes P: Connective tissue growth factor and its regulation: A new element in diabetic glomerulosclerosis. Ren Fail 23: 459-470, 2001
12. Igarashi A, Okochi H, Bradham DM, Grotendorst GR: Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. Mol Biol Cell 4: 637-645, 1993
13. Kothapalli D, Frazier KS, Welply A, Segarini PR, Grotendorst GR: Transforming growth factor beta induces anchorage-independent growth of NRK fibroblasts via a connective tissue growth factor-dependent signaling pathway. Cell Growth Differ 8: 61-68, 1997
14. Frazier K, Williams S, Kothapalli D, Klapper H, Grotendorst GR: Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. J Invest Dermatol 107: 404-411, 1996
15. Pendurthi UR, Allen KE, Ezban M, Roa LV: Factor VIIa and thrombin induce the expression of Cyr61 and connective tissue growth factor, extracellular matrix signaling proteins that could act as possible downstream mediators in factor VIIa tissue factor-induced signal transduction. J Biol Chem 275: 14632-14641, 2000
16. Suzama K, Naruse K, Suzama I, Takahara N, Ueki K, Aiello LP, King GL: Vascular endothelial growth factor induces the expression of connective tissue growth factor via KDR. Flt 1: and phosphatidylinositol 3-kinase-akt-dependent pathways in retinal vascular cells. J Biol Chem 275: 40725-40731, 2000
17. Ito Y, Aten J, Bende RJ, Oemar BS, Rabelink TJ, Weening JJ, Goldschmeding R: Expression of connective tissue growth factor in human renal fibrosis. Kidney Int 53: 853-861, 1998
18. Wang S, Denichilo M, Brubaker C, Hirschberg R: Connective tissue growth factor in tubulointerstitial injury of diabetic nephropathy. Kidney Int 60: 96-105, 2001
19. Riser BL, Denichilo M, Cortes P, Baker C, Grondin JM, Yee J, Narins RG: Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis. J Am Soc Nephrol 11: 25-38, 2000
20. Ikeda S, Makino H, Haramoto T, Shikata K, Kumagai I, Ota Z: Changes in glomerular extracellular matrices components in diabetic nephropathy. J Diabet Complications 5: 186-188, 1991
21. Abdel Wahab N, Harper K, Mason R: Expression of extracellular matrix molecules in human mesangial cells in response to prolonged hyperglycaemia. Biochem J 316: 985-992, 1996
22. Oh JH, Ha H, Yu MR, Lee HB: Sequential effects of high glucose on mesangial cell transforming growth factor-beta 1 and fibronectin synthesis. Kidney Int 54: 1872-1878, 1998
23. Ayo SH, Radnik RA, Glass WF 2nd, Garoni JA, Rampt ER, Appling DR, Kreisberg JI: Increased extracellular-matrix synthesis in mesangial cells grown in high-glucose medium. Am J Physiol 260: F185-F191, 1991
24. Scharzbauer JE, Sechler J: Fibronectin fibrillogenesis: a paradigm for extracellular matrix assembly. Curr Opin Cell Biol 11: 622-627, 1999
25. Fogerty FJ, Akiyama SK, Yamada KM, Mosher DF: Inhibition of binding of fibronectin to matrix assembly sites by anti-integrin (α5β1) antibodies. J Cell Biol 111: 699-708, 1990
26. Akiyama SK, Yamada SS, Chen WT, Yamada KM: Analysis of fibronectin receptor function with monoclonal antibodies: Roles in cell adhesion, migration, matrix assembly and cytoskeletal organization. J Cell Biol 109: 863-875, 1989
27. Kagami S, Border WA, Ruoslahti E, Noble NA: Coordinated expression of beta 1 integrins and transforming growth factor-beta-induced matrix proteins in glomerulonephritis. Lab Invest 69: 68-76, 1993
28. Kuhara T, Kagami S, Kuroda Y: Expression of beta-1 integrins on activated mesangial cells in human glomerulonephritis. J Am Soc Nephrol 8: 1679-1687, 1997
29. Cai T, Lei QY, Wang LY, Zha XL: TGF-β1 modulated the expression of α5β1 integrin and integrin-mediated signalling in human hepatocarcinoma cells: Biochem Biophys Res Comm 274: 519-525, 2000
30. Collo G, Pepper MS: Endothelial cell integrin alpha5beta1 expression is modulated by cytokines and during migration in vitro. J Cell Sci 112: 569-578, 1999
31. Kagami S, Kuhara T, Yasutomo K, Okada K, Löster K, Reutter W, Kuroda Y: Transforming growth factor-β (TGF- β) stimulates the expression of β1 integrins and adhesion by rat mesangial cells. Exp Cell Res 229: 1-6, 1996
32. Weston BS, Abdel-Wahab N, Roberts T, Mason RM: Bacitracin inhibits fibronectin matrix assembly by mesangial cells in high glucose. Kidney Int 60: 1756-1765, 2001
33. Mould AP, Garratt AN, Askari JA, Akiyama SK, Humphries MJ: Identification of a novel anti-integrin monoclonal antibody that recognises a ligand-induced binding site epitope on the beta 1 subunit. FEBS Lett 363: 118-122, 1995
34. Chomczynski P, Sacchi N: Single step methods of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987
35. Nista A, Leonetti C, Bernardini G, Mattioni M, Santoni A: Functional role of alpha4beta1 and alpha5beta1 integrin fibronectin receptors expressed on adriamycin-resistant MCF-7 human mammary carcinoma cells. Int J Cancer 72: 133-141, 1997
36. Damsky CH, Fitzgerald M, Fisher SJ: Distribution patterns of extracellular matrix components and β1 integrin receptors are intricately modulated during differentiation of human cryotrophoblast to an invasive phenotype in vivo. J Clin Invest 89: 210-222, 1992
37. Gauer S, Yao J, Schoecklmann HO, Sterzel RB: Adhesion molecules in the glomerular mesangium. Kidney Int 51: 1447-1453, 1997
38. Geiger B, Bershadsky A, Pankov R, Yamada KM: Transmembrane extracellular matrix-cytoskeleton crosstalk. Nature Reviews Mol Cell Biol 2: 793-805, 2001
39. Border WA: Transforming growth factor-beta and the pathogenesis of glomerular diseases. Curr Opin Nephrol Hypertens 3: 54-58, 1994
40. Dammeier J, Brauchle M, Falk W, Grotendorst GR, Werner S: Connective tissue growth factor: A novel regulator of mucosal repair and fibrosis in inflammatory bowel disease? Int J Biochem Cell Biol 30: 909-922, 1998
41. Manabe R, Oh-e N, Maeda T, Fukuda T, Sekiguchi K: Modulation of the cell-adhesive activity of fibronectin by the alternatively spliced EDA segment. J Cell Biol 139: 295-307, 1997
42. Stephens PE, Ortlepp S, Perkins VC, Robinson MK, Kirby H: Expression of a soluble functional form of the integrin alpha4beta1 in mammalian cells. Cell Adhes Commun 7: 377-390, 2000
43. Kainoh M, Tanaka T: Production of soluble integrin alpha2beta1 heterodimer complex functionally active in vitro and in vivo. Biochem Biophys Res Commun 290: 305-310, 2002